The Biotech Moonshots & Startup Lift off from Lab to Launch
–
June 8, 2022
Karl Handelsman is the Founder and General Partner of Codon Capital, established in 2013 to invest in early-stage biotech teams uniquely qualified to build breakthrough technical solutions in therapeutics and synthetic biology. Karl has been working with extraordinary teams that have a track record of success for over 20 years. Codon supports teams in advance of the Series A to discover the highest value product for their technology. Codon also helps teams establish a capital efficient development plan with the goal of demonstrating value within 18 months of the Series A financing. During this seminar, Karl will walk you through the journey of becoming a founder and entrepreneur.